2Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC cancer staging manual esophagus and esopha- gogastric junction [J ]. Ann Surg Oncol, 2010, 17 ( 7 ) 1721-1724.
3Miwa S, Takeuchi A, Ikeda H, et al. Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft [J]. PLoS One,2013,8(8) :e71362.
4Yuan D, Liu B, Liu K, et al. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosareoma[J]. J Surg Oncol, 2013,108 (3) : 157- 162.
5Gong L,Liu W,Sun X,et al. Histological and clinical charac- teristics of malignant giant cell tumor of bone[J]. Vir- chows Arch, 2012,460 (3) :327-334.
6Nikitenko LL, Fox SB, Kehoe S, et al. Adrenomedullin and tumour angiogenesis[J]. Brit J Cancer, 2005,94 (1) : 17.
7Dai X, Ma W, He XJ, et al. Elevated expression of ad- renomedullin is correlated with prognosis and disease se- verity in osteosareoma[J]. Med Oncol, 2013,30 ( 1 ) : 347.
8Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endoeytic transport[J]. Nat Rev Mol Cell Biol,2009,10(12) :843-853.
9Lakshmikanthan S, Sobczak M, Chun C, et al. Rap1 pro- motes VEGFR2 activation and angiogenesis by a mecha- nism involving integrin alphavbeta ( 3 ) [ J]. Blood, 2011, 118(7) :2015-2026.
10Lorger M, Krueger JS, Or Neal M, et al. Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain[J]. Proc Natl Acad Sci U S A,2009,106(26) :10666-10671.
